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Abstract
To investigate the possible role of nitric oxide (NO) produced locally or intramurally in the
quiescence of the pregnant myometrium, nitric oxide synthase (NOS) activity was measured in
samples from first trimester (villous, and non villous-trophoblast), term placenta and pregnant
myometrium. Trophoblast tissue was obtained from psychosocial termination of pregnancy (9 – 12
weeks' gestation) whereas placenta and myometrium, from the same patient, at deliveries by
Caesarean section. NOS activity was measured in both cytosolic and particulate fractions by the
formation of 14C-citrulline from 14C-arginine. Western immunoblotting was used to identify the
endothelial NOS (eNOS) and neuronal (nNOS) isoforms. The activity of NOS in particulate
fractions from all preparations was considerably higher than the cytosolic fractions. Activity in all
fractions except the myometrium was highly Ca-dependent. More than 50% of particulate NOS
from the myometrium was Ca-independent. NOS activity was highest in the villous trophoblast and
there was a significant difference between the villous and non-villous trophoblast. In placenta and
myometrium, NOS was 2–4 fold and 20–28-fold lower than the villous trophoblast, respectively.
Western blot analysis showed clearly eNOS in the particulate fraction and a weak eNOS band in
the cytosolic fractions, whereas nNOS was not detectable in any of the fractions. In view of the
marginal activity of NOS in the myometrium, NO produced by the trophoblast and placenta could
play a significant role in maintaining uterine quiescence by paracrine effect.
Background
Nitric oxide (NO) is a multifunctional signal and impor-
tant modulator of cellular responses in a variety of tissues
including those involved in human reproduction. NO is
generated from L-arginine by the catalytic action of the
enzyme, nitric oxide synthase (NOS). So far three differ-
ent isoform of NOS have been identified, cloned and
characterised. While two of the three (type I or neuronal
and III or endothelial) are constitutively expressed in a
variety of tissues, the expression of the third isoform (type
II or inducible) can be induced by cytokines and some
other agents [1–3].
NO is known to have a powerful vasodilatory effect in
resistance vessels throughout the body. This action is,
however, mediated by locally produced NO and in most
instances by the subsequently generated second messen-
ger guanosine 3–5 cyclic monophosphate (cGMP).
There is considerable evidence that local production of
NO contributes to the maintenance of low vascular
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resistance in the fetoplacental circulation [4.6]. Since
umbilical cord and chorionic plate vessels are unlikely to
contribute greatly to the regulation of fetoplacental blood
flow because of their large calibre, stem villous arterioles
of the placenta are thought to be the major site of resist-
ance. The biosynthesis of NO and cGMP is increased dur-
ing pregnancy in rat and sheep [7,9] and NO was reported
to decrease in rats at parturition [10,11], but the evidence
in human is inconclusive.
The histological unit of the placenta consists of villous tro-
phoblast and non-villous trophoblast, remaining tro-
phoblast not used for villous formation, found in all other
parts of the placenta: cell columns, cell islands, chorionic
plate, membranes, septa, basal plate and spiral arteries
[12].
The villous cytotrophoblast is the inner layer of the villous
surface trophoblast whereas the villous syncytiotrophob-
last is the superficial layer facing the intervillous space.
Formation of NO by placental NOS, released in the inter-
villous space, may prevent platelet adhesion and aggrega-
tion and importantly contribute to dilatation of villous
smooth muscle [12,13]. The trophoblast is considered to
be important in implantation, placental development and
adhesion of the placenta to the uterine wall, which are
mediated by invasion of extravillous trophoblast into the
endometrium [12,13]. The villous trophoblast is consid-
ered to be largely responsible for the regulation of blood
perfusion in the fetus.
NOS has been identified in human placenta at term as
well as primordial placenta [14,15]. The NOS activity in
these tissues was found to be highly Ca-dependent sug-
gesting constitutive NOS. The activity was largely found in
the microsomal (particulate) fraction. Our recent studies
in rat and rabbit reproductive tract tissue have shown that
NOS activity was predominantly found in the cytosolic
fraction [17,18]. Ramsay et. al presented data on NOS
activity in the villous trophoblast in the three trimesters of
pregnancy and found the highest activity in the first tri-
mester [19]. It has been suggested that production of NO
by placenta would be an important factor acting in a para-
crine manner to contribute to uterine quiescence [19,20].
From our recent studies showing important differences
between NOS activity in human and rat or rabbit myo-
metrium, it was concluded that placental and fetal NOS
could be of considerable importance in maintaining qui-
escence of the myometrium in human pregnancy [21].
In order to gain further insight into the functional role of
NOS in trophoblast, we have in the present study
obtained data on the NOS activity in cytosolic and partic-
ulate fractions prepared from villous and non-villous tro-
phoblast. For both comparison with trophoblast and
elucidation of any paracrine effect, NOS activity was also
measured in term placenta and pregnant myometrium.
Methods
The study was approved by the local Ethics committee
(University Hospital, Lund, Sweden) and informed con-
stant was obtained from all patients.
Samples from primordial human placentae were obtained
from psychosocial termination of pregnancy between 9 –
12 weeks gestation (n = 17). Pregnancies were dated by
measuring crown rump length using transvaginal ultra-
sound approximately one week prior to the termination.
Samples were obtained by suction and curettage. Term
placenta and myometria were obtained from deliveries by
elective Caesarean section (n = 15).
After washing the first trimester samples 3 times in ice-
cold saline solution, villous tissue was separated by care-
ful scraping and both villous and non-villous trophoblast
tissue were collected. A sample approximately 2–3 g of tis-
sue was excised from the term placenta near the insertion
of umbilical cord. Myometrial tissue (approximately 3 cm
× 0.5 cm) was obtained from the upper margin of the
transverse section in the lower uterine segment. All tissues
were rinsed with ice-cold saline and frozen by immersion
in liquid nitrogen and stored at -80°C until used (within
3 weeks) for the experiment.
In addition, five samples were collected from each tissue
for histological tissue control. These samples were fixed in
formalin, paraffin embedded and stained with
haematoxylin-eosin.
Preparation of subcellular fractions
The frozen tissues were thawed and then homogenised in
approximately 10 vol. buffer containing 320 mM sucrose,
10 mM HEPES buffer (pH 7.5), 0.1 mM EGTA, 1 mM DTT,
10 µg/ml trypsin inhibitor, 10 µg/ml leupeptin and 2 µg/
ml aprotinin with a Polytron homogenizer for four peri-
ods of 15 s (per gram tissue) with intermittent cooling
pauses of 20 s. The homogenate was centrifuged at 1000 g
for 10 minutes and the pellet was discarded. The superna-
tant was filtered through one layer of gauze and centri-
fuged 40.000 g for 45 minutes and the pellet and
supernatant were saved as cytosolic and particulate frac-
tions, respectively. In some experiments the above pellet
was suspended in 1 M KCl and centrifuged to remove any
bound cytosolic NOS. There was no significant difference
in the specific NOS activity between the unwashed pellet
and pellets washed with 1 M KCl.
Measurement of NOS activity
NOS activity was determined by measuring the formation
of  14C-citrulline from 14C-arginine essentially accordingReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/51
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to the procedure described by Salter et al.18 Incubation
mixture contained 20 µL of cytosolic or particulate frac-
tions (40 – 60 µg protein) added to 100 µL of phosphate
buffer containing 50 mM K-phosphate (pH 7.5), 1.2 mM
MgCl2, 0.24 mM CaCl2, 50 mM valine, 0.1 mM β-nicoti-
namide adenine dinucleotide phosphate (NADPH), 1
mM citrulline, 2-µM flavin adenine dinucleotide (FAD), 2
µM flavin mononucleotide (FMN), 10 µM tetrahydro-L-
biopterin (BH4), 50 IU/mL calmodulin, 20 µM arginine
and 0.6 – 0.8 µM [-14C] arginine (sp. Act 0.32 Ci/mM).
Samples were incubated for 20 minutes at 28°C. Prelimi-
nary experiments showed that the reaction was linear for
at least 30 minutes. Incubation was terminated by
removal of substrate and dilution by addition of 1.5 mL
of 1:1 (v/v) pre-washed resin. AG50W-X8, in ice-cold
water, and measured for quantification of [-14C] citrulline
by liquid scintillation spectrometry.
Protein concentrations in subcellular fractions were deter-
mined by method of Peterson using bovine serum albu-
min as standard [23].
Presentation of data
Specific NOS activity (in pmol/mg protein/min) is
reported as the difference between the activity (total) and
that in the presence of the inhibitor 1 mM L-NAME and 1
mM EGTA (non-specific). Calcium independent activity
was the activity measured in the incubation mixture lack-
ing CaCl2 and containing 1 mM EGTA.
Student's  t-test was used for statistical analysis of the
observed differences.
Western blots
Aliquots of 50 µl of supernatant or particulate fraction
were diluted 1:2 in electrophoresis sample buffer (62.5
nM Tris-HCL, pH 6.8, 25% glycerol, 2% SDS, 0.01%
bromophenol blue and 5% β-mercaptoethanol) to yield a
protein amount of 10 µl/cell and 30 µl/cell for endothelial
NOS (eNOS) and neuronal NOS (nNOS) analysis, respec-
tively. The samples were reduced by boiling for 5 min.
Human placenta and rat cerebral cortex were used as a
positive control for eNOS and nNOS, respectively.
Sodium dodecyl sulphate-polyacryl-amide gel electro-
phoresis (SDS-PAGE) was carried out on a 7% polyacryla-
mide gel at 200 V for 30 min.
After electrophoretic transfer to a PVDF membrane at 10–
15 V for 30 min, blocking with dry milk diluted in TBS-
Tween was carried out over night at 4°C. The blots were
then incubated with primary polyclonal antibodies
diluted in TBS-Tween dry milk (eNOS 1:2000 and nNOS
1:1000) for 1 h at room temperature. The blots were
rinsed in TBS-Tween for 1 × 15 min followed by 3 × 5 min
and incubated with secondary anti-rabbit IgG-HRP
diluted in TBS-Tween (1:10 000) for 1 h at room temper-
ature. The blots were rinsed as above and then subjected
to enhanced chemiluminescence (ECL) using the Western
blot detection system. Autoradiographic film was applied
to the blot until satisfactory exposure was obtained.
Results
Figure 1 shows NOS activity in both particulate and
cytosolic fractions prepared from villous and non-villous
trophoblast, both total and Ca-independent activities are
shown. The activity of NOS in particulate fractions from
both preparations was considerably higher than the
cytosolic fractions.
In villous trophoblast the total activity in the particulate
fraction was 3-fold higher than the cytosolic fraction. The
Ca-independent activities in both fractions were similar
and very low, compared with the total.
In non-villous trophoblast NOS activity was also higher in
particulate than in the cytosolic fraction, but Ca-inde-
pendent activity in the two fractions was nearly the same.
The particulate NOS in the villous was 2–3-fold higher
than that in the non-villous trophoblast and the differ-
ence was statistically significant (P < 0.01), but Ca-inde-
pendent NOS in particulate fraction from villous and
non-villous trophoblast was similar. In villous trophob-
last, the total cytosolic NOS was nearly 3-fold higher than
that in the non-villous trophoblast and the difference
NOS activity in particulate (par) and cytosolic (cyt) fractions  isolated from early placenta (first trimester) villous (n = 17)  and non-villous (n = 17) trophoblasts Figure 1
NOS activity in particulate (par) and cytosolic (cyt) fractions 
isolated from early placenta (first trimester) villous (n = 17) 
and non-villous (n = 17) trophoblasts. Significance of differ-
ences between villous and extravillous are shown by ** (p < 
0.01) and *** (p < 0.005).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/51
Page 4 of 7
(page number not for citation purposes)
between the two was highly significant (P < 0.005), but
the Ca-independent NOS was similar.
Histological examination of villous samples showed that
they consisted predominantly of villi covered by villous
trophoblasts (Fig. 2). Samples from non-villous trophob-
last showed a predominance of connective tissue
(stroma), limited amount of non-villous trophoblast and
few villi (Fig. 3).
Figure 4 shows both total and Ca-independent NOS activ-
ities in the placenta and myometrium obtained from the
same patients. In these tissues the NOS activity was mark-
edly low compared to the villous and extravillous tro-
phoblast, by about 3–5-fold.
Although, NOS in the placenta was predominantly partic-
ulate bound, the cytosolic fraction contained considerable
amount of NOS, being nearly 60% of that in the particu-
late fraction. The Ca-independent activity was very low
being less than 15% of the total. The NOS activity in pla-
centa was considerably lower than the villous trophoblast,
being more than 4-fold and 2-fold lower in particulate
and cytosolic fraction, respectively. Although placental
particulate NOS was lower and the cytosolic NOS higher
than the corresponding fractions in non-villous trophob-
last, the difference was not statistically significant.
In the myometrium the concentration of NOS was very
low in both the particulate and cytosolic fractions being 6
– 9-fold lower than the corresponding fractions from pla-
centa. A considerable portion of the total activity in the
particulate fraction, which was the predominant form was
General view of the villous sample from first trimester show- ing a predominance of villous-trophoblast Figure 2
General view of the villous sample from first trimester show-
ing a predominance of villous-trophoblast. (Hematoxylin-
eosin, 60×)
General view of the non-villous sample from first trimester  showing a predominance of stromal connective tissue and  limited amounts of non-villous trophoblast Figure 3
General view of the non-villous sample from first trimester 
showing a predominance of stromal connective tissue and 
limited amounts of non-villous trophoblast. (Hematoxylin-
eosin, 60×)
NOS activity in particulate (par) and cytosolic (cyt) fractions  isolated from placenta (n = 15) and pregnant myometrium (n  = 14) Figure 4
NOS activity in particulate (par) and cytosolic (cyt) fractions 
isolated from placenta (n = 15) and pregnant myometrium (n 
= 14). Significance of difference, between placenta and myo-
metrium is shown by *** (p < 0.005).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/51
Page 5 of 7
(page number not for citation purposes)
Ca-independent, as it was more than 50% of the total
activity. There was no correlation between myometrial
and placental activities, in the individual patients (data
not shown).
Histological examination of term placenta samples
showed an even mixture of villi covered by villous tro-
phoblast and connective tissue (stroma) from villi and
septae (Fig. 5).
Data on Western blot analysis performed on particulate
and cytosolic fractions of non-villous and villous tro-
phoblast is shown in Figure 6. The eNOS antibody reacted
with a 133 kDa protein corresponding to the size of
eNOS. In both villous and non-villous trophoblast dense
bands corresponding to eNOS can be seen. In addition a
very faint band could also been seen in the cytosolic frac-
tion from the villous trophoblast. The fractions from
human myometrium showed a specific band of 133 kDa,
corresponding to eNOS, which was detected in particulate
but not cytosolic fractions (Fig. 7). In the fractions from
placenta a band corresponding to eNOS was clearly seen
in the particulate fraction and again a faint band in the
cytosolic fraction.
The nNOS antibody showed a clear and intense reactivity
with a 161 kDa protein from rat cortex (positive control),
which corresponds to the expected size of nNOS. How-
ever, with this antibody we were unable to see any reac-
tion in cytosolic or the particulate fraction from any of the
tissues.
Discussion
In the present study we have measured NOS activities in
human trophoblast from early placenta (first trimester),
term placental and myometrium. A recent immunohisto-
chemical study on trophoblastic NOS has demonstrated
the presence of NOS in microvilli as well as in extravillous
trophoblastic cells at the implantation site [13]. It was,
therefore, of interest to quantify NOS activities in villi and
non-villous cells of the trophoblast both in early placenta
(first trimester) and term placenta and further investigate
whether there were any differences in their subcellular dis-
tribution and Ca-dependence.
In agreement with the above immunohistochemical study
[13], we have found considerable NOS activity in particu-
larly the villous trophoblast. Ramsay et al. have recently
presented data on villous trophoblast in each of the three
trimesters during pregnancy, but only cytosolic
(supernatant) activity was analysed in their samples [19].
The mean values for NOS activity in trophoblast from the
first trimester, in their data, are generally comparable with
the present data on cytosolic fractions. We have, however,
found that NOS is much more concentrated in the
particulate fraction than the cytosolic fraction, but the
former was not analysed in the study by Ramsay et al [19].
In view of the fact that in the present study, an expression
of nNOS was not seen in Western blots, it is likely that the
activity measured in cytosolic fraction is by and large a
Microscopic appearance of the term placenta sample showing  a mixture of villous-trophoblast (villi) and stromal connective  tissue from villi and septae Figure 5
Microscopic appearance of the term placenta sample showing 
a mixture of villous-trophoblast (villi) and stromal connective 
tissue from villi and septae. (Hematoxylin-eosin, 60×)
Western blots of particulate (P) and cytosolic (C) fractions  isolated from non-villous and villous trophoblasts (first tri- mester) using an antibody directed against eNOS Figure 6
Western blots of particulate (P) and cytosolic (C) fractions 
isolated from non-villous and villous trophoblasts (first tri-
mester) using an antibody directed against eNOS. The puta-
tive bands are seen at 135 kDa corresponding to eNOS 
protein.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/51
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result of contamination of this fraction with particles orig-
inally associated with the particulate fraction. This con-
tamination most probably occurred during the isolation
of the fractions. This is supported by the present data
showing cross-reactivity in the cytosolic fraction particu-
larly from placenta and villi with a protein corresponding
to eNOS, which is predominantly associated with the par-
ticulate fraction. A contamination of the cytosolic fraction
with fragments from the particulate fraction as suggested
by the present findings would apparently vary depending
on the method of preparation, which should be impor-
tantly considered when comparing the subcellular distri-
bution of NOS reported in various studies, in addition to
consideration of differences in organs and species (24).
Intimate relationship exists between maternal blood and
trophoblastic cells in the implantation site. It is
conceivable that relaxation of the vascular wall of muscles
at the implantation site by NO may be produced by
extravillous trophoblastic cells. This would be consistent
with the present finding of a considerable NOS activity in
non-villous trophoblast. However, significantly higher
activity was found in the villous trohpoblast suggesting a
relation between number of trophoblastic cells and NOS
activity.
Due to the highly proliferative and invasive nature of tro-
phoblastic cells in early pregnancy as they penetrate the
endometrium, one might expect an inducible Ca-inde-
pendent NO (Type II), particularly in the extravillous tro-
phoblast. In the present data we found that in contrast to
the villous, the non-villous trophoblast had a considera-
ble Ca-independent NOS as it was approximately half of
the total activity in the cytosol. Corresponding figure for
the villous trophoblast was only 15%. Ramsay et al. have
also reported that only a very small portion of total NOS
in the cytosol of villous trophoblast was Ca-independent
[19].
The NOS activity in the placenta at term was considerably
lower than in samples from early placenta (first trimester),
which is in agreement with the recent immunohistochem-
ical study [13]. The histological examination of the
samples showed less villous trophoblast when compared
with samples from early placenta (first trimester). Our
data on Ca-dependent and Ca-independent activities in
placenta are in agreement with the recently published
data [14,15]. A higher activity in trophoblast in early preg-
nancy than in term placenta might be expected due to a
heavy demand placed on the utero-placental circulation
which is achieved by decreased resistance to blood flow. It
is, however, possible that NOS activity in trophoblastic
cells surrounding the spiral arteries as well as in the spiral
arteries themselves at term may be of greater significance
than the activity in the rest of the placenta [25,26].
The present data showing very low NOS activity in the
human pregnant myometrium would suggest that it is
unlikely that a local production of NO in the myo-
metrium plays an important role in the maintenance of
uterine quiescence. On the contrary, it is probable that
trophoblastic NOS activity, which in relatively high both
in villous and non-villous cells may have a paracrine effect
during early pregnancy on the myometrium and thereby
contribute to maintenance of uterine quiescence [27].
From the data of our recent study it was suggested that
increasing levels of estrogen and progesterone could con-
tribute to a downregulation of NOS activity in myo-
metrium during pregnancy (24). This suggestion is
consistent with present data showing higher NOS activity
in early placenta (first trimester) than in term placenta.
Similar paracrine effect of placental NOS activity, which
was 2–4-fold higher than the myometrium, could be
envisioned during late pregnancy [26]. It should be
emphasized, however, that the villous and non-villous
trophoblast represents a major cellular component related
to both the maternal (intervillous space) and fetal (villi)
circulation suggesting also a major role in the haemody-
namic control of these circulations.
Studies in animals not only provide a strong support for a
paracrine role of placental NO but also led to the sugges-
tion that fetal-placental unit increases the availability of
NO generated by NO donors [27–29]. In a recent study it
was suggested that NO synthesised in fetal membranes
may act either directly to inhibit myometrial contractility
Western blots of particulate (P) and cytosolic (C) fractions  isolated from myometrium and term placenta using an anti- body directed against eNOS Figure 7
Western blots of particulate (P) and cytosolic (C) fractions 
isolated from myometrium and term placenta using an anti-
body directed against eNOS. The bands are seen at 135 kDa 
corresponding to eNOS protein.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/51
Page 7 of 7
(page number not for citation purposes)
or indirectly through an interaction with cyclooxygenase
[31]. This would also apply to NO produced by
trophoblasts and placenta, which appear to be the major
sources of NO production during pregnancy.
Data from the current study demonstrate considerable
amounts of NOS activity in both trophoblastic villi and
extravillous cells and suggest a physiologic role of tro-
phoblastic NO in early stages of pregnancy. Appreciable
concentration of NOS was found in term placenta and
very low in the myometrium but there was no correlation
between the myometrial and placental activities. Further
work is needed to establish the role of NO produced at
specific sites in the uteroplacental circulation and para-
crine effect of trophoblastic NOS in maintenance of uter-
ine quiescence during pregnancy.
Conclusion
In view of the marginal activity of NOS in the pregnant
myometrium, NO produced by the trophoblast and pla-
centa could play a significant role in maintaining uterine
quiescence by paracrine effect.
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